Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to EPICYPHER in May, 2021 for $1,012,272.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI162386-01 | Phase II | 1,012,272 | May 5, 2021 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in July, 2021 for $306,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI165019-01 | Phase I | 306,500 | July 1, 2021 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in September, 2020 for $978,257.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DE029633-02 | Phase II | 978,257 | September 13, 2020 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in September, 2021 for $1,024,752.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HG010595-02 | Phase II | 1,024,752 | September 9, 2021 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in September, 2021 for $301,921.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK131770-01 | Phase I | 301,921 | September 15, 2021 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in February, 2020 for $920,218.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM136172-01 | Phase II | 920,218 | February 3, 2020 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in February, 2020 for $993,542.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI134162-02 | Phase II | 993,542 | February 25, 2020 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in April, 2021 for $1,024,878.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM140536-01A1 | Phase II | 1,024,878 | April 6, 2021 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in December, 2019 for $910,411.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HG011006-01 | Phase II | 910,411 | December 5, 2019 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in January, 2019 for $299,923.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM131560-01 | Phase I | 299,923 | January 1, 2019 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in August, 2019 for $300,055.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM134834-01 | Phase I | 300,055 | August 15, 2019 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in September, 2019 for $259,086.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DE029633-01 | Phase I | 259,086 | September 13, 2019 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in September, 2020 for $396,808.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HG010640-01A1 | Phase I | 396,808 | September 1, 2020 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in September, 2021 for $1,024,792.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44HG010640-02 | Phase II | 1,024,792 | September 1, 2021 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in March, 2018 for $2,109,334.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA212733-02 | Phase II | 2,109,334 | March 1, 2018 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in September, 2018 for $284,818.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA236474-01 | Phase I | 284,818 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in June, 2018 for $1,719,769.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM123869-02 | Phase II | 1,719,769 | June 1, 2018 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in March, 2018 for $300,244.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM126724-01 | Phase I | 300,244 | March 1, 2018 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in January, 2022 for $1,024,329.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM145007-01 | Phase II | 1,024,329 | January 20, 2022 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in May, 2022 for $1,025,085.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44TR004227-01 | Phase II | 1,025,085 | May 1, 2022 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in June, 2022 for $1,024,490.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM131560-02 | Phase II | 1,024,490 | June 1, 2022 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in September, 2022 for $978,127.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK131770-02 | Phase II | 978,127 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in September, 2022 for $406,352.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM148145-01 | Phase I | 406,352 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to EPICYPHER in September, 2022 for $326,506.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA057749-01 | Phase I | 326,506 | September 15, 2022 | |||||||
A SBIR Phase II contract was awarded to EPICYPHER in August, 2022 for $1,022,665.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI167215-01A1 | Phase II | 1,022,665 | August 18, 2022 |